These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9713446)

  • 1. Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts.
    Mapel DW; Hunt WC; Utton R; Baumgartner KB; Samet JM; Coultas DB
    Thorax; 1998 Jun; 53(6):469-76. PubMed ID: 9713446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
    Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
    Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
    Doubková M; Uher M; Bartoš V; Šterclová M; Lacina L; Lošťáková V; Binková I; Plačková M; Žurková M; Bittenglová R; Pšikalová J; Šišková L; Lisá P; Petřík F; Polák J; Řihák V; Skřičková J; Vašáková M
    Cas Lek Cesk; 2016; 155(4):22-8. PubMed ID: 27481198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.
    Ryerson CJ; Hartman T; Elicker BM; Ley B; Lee JS; Abbritti M; Jones KD; King TE; Ryu J; Collard HR
    Chest; 2013 Jul; 144(1):234-240. PubMed ID: 23370641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.
    Jo HE; Glaspole I; Grainge C; Goh N; Hopkins PM; Moodley Y; Reynolds PN; Chapman S; Walters EH; Zappala C; Allan H; Keir GJ; Hayen A; Cooper WA; Mahar AM; Ellis S; Macansh S; Corte TJ
    Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28232409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.
    Collard HR; Ryu JH; Douglas WW; Schwarz MI; Curran-Everett D; King TE; Brown KK
    Chest; 2004 Jun; 125(6):2169-74. PubMed ID: 15189938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
    Li ZH; Peng SC; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis.
    Tran T; Šterclová M; Mogulkoc N; Lewandowska K; Müller V; Hájková M; Kramer MR; Jovanović D; Tekavec-Trkanjec J; Studnicka M; Stoeva N; Hejduk K; Dušek L; Suissa S; Vašáková M;
    Respir Res; 2020 Jan; 21(1):11. PubMed ID: 31915023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
    Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
    BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index and mortality in patients with idiopathic pulmonary fibrosis.
    Alakhras M; Decker PA; Nadrous HF; Collazo-Clavell M; Ryu JH
    Chest; 2007 May; 131(5):1448-53. PubMed ID: 17400656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
    Tzouvelekis A; Herazo-Maya JD; Slade M; Chu JH; Deiuliis G; Ryu C; Li Q; Sakamoto K; Ibarra G; Pan H; Gulati M; Antin-Ozerkis D; Herzog EL; Kaminski N
    Respirology; 2017 Apr; 22(3):486-493. PubMed ID: 27761978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung transplantation for idiopathic pulmonary fibrosis.
    Mason DP; Brizzio ME; Alster JM; McNeill AM; Murthy SC; Budev MM; Mehta AC; Minai OA; Pettersson GB; Blackstone EH
    Ann Thorac Surg; 2007 Oct; 84(4):1121-8. PubMed ID: 17888957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study.
    Hubbard R; Johnston I; Britton J
    Chest; 1998 Feb; 113(2):396-400. PubMed ID: 9498958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial lung disease clinics for the management of idiopathic pulmonary fibrosis: a potential advantage to patients. Greater Manchester Lung Fibrosis Consortium.
    Lok SS
    J Heart Lung Transplant; 1999 Sep; 18(9):884-90. PubMed ID: 10528751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.
    Kohashi Y; Arai T; Sugimoto C; Tachibana K; Akira M; Kitaichi M; Hayashi S; Inoue Y
    Respiration; 2016; 92(4):220-228. PubMed ID: 27576553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Kramer MR
    Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis.
    McCormack FX; King TE; Bucher BL; Nielsen L; Mason RJ
    Am J Respir Crit Care Med; 1995 Aug; 152(2):751-9. PubMed ID: 7633738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
    Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
    Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage.
    Shioya M; Otsuka M; Yamada G; Umeda Y; Ikeda K; Nishikiori H; Kuronuma K; Chiba H; Takahashi H
    Can Respir J; 2018; 2018():6043053. PubMed ID: 30186537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.